The Scurry County Hospital District
will propose a tax decrease when it begins
budget sessions this year, members
of the finance committee learned Wednesday.
With preliminary certified values up some $500 million over last year's $3.04 billion certified values, a 15.58 percent increase, Chief Financial Officer John Everett told the panel that the current tax rate could be dropped from the 27 cents per $100 valuation to 25.22 cents.
Russell Riggan noted that the hospital was within $100,000 of supporting its operations without the need for ad valorem taxes.
The committee also learned that the Medicaid disproportionate share fund has sent the hospital some $120,000 after several months of no payments.
The share to the hospital will decrease approximately 25 percent next year.
Additionally, the hospital will take another hit.
Committee members learned that tobacco settlement money would not be distributed next year.
"While the tobacco companies are still distributing money to the state of Texas, the state has decided to keep the money rather than disburse it," said Dr. Bill Weldon, interim chief executive officer.
With preliminary certified values up some $500 million over last year's $3.04 billion certified values, a 15.58 percent increase, Chief Financial Officer John Everett told the panel that the current tax rate could be dropped from the 27 cents per $100 valuation to 25.22 cents.
Russell Riggan noted that the hospital was within $100,000 of supporting its operations without the need for ad valorem taxes.
The committee also learned that the Medicaid disproportionate share fund has sent the hospital some $120,000 after several months of no payments.
The share to the hospital will decrease approximately 25 percent next year.
Additionally, the hospital will take another hit.
Committee members learned that tobacco settlement money would not be distributed next year.
"While the tobacco companies are still distributing money to the state of Texas, the state has decided to keep the money rather than disburse it," said Dr. Bill Weldon, interim chief executive officer.
